The apelinergic-axis in human preeclamptic pregnancies: A systematic review

O’Dowd, 1993, A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11, Gene, 136, 355, 10.1016/0378-1119(93)90495-O Tatemoto, 1998, Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor, Biochem. Biophys. Res. Commun., 251, 471, 10.1006/bbrc.1998.9489 Szokodi, 2002, Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility, Circ. Res., 91, 434, 10.1161/01.RES.0000033522.37861.69 K. Tatemoto, M. Hosoya, Y. Habata et al., Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor, Elsevier. (n.d.). https://www.sciencedirect.com/science/article/pii/S0006291X9899489X (accessed January 17, 2019). The Human Protein Atlas, Tissue expression of APLN - Summary - The Human Protein Atlas, (n.d.). https://www.proteinatlas.org/ENSG00000171388-APLN/tissue#gene_information (accessed January 17, 2019). The Human Protein Atlas, Tissue expression of APLNR - Summary - The Human Protein Atlas, (n.d.). https://www.proteinatlas.org/ENSG00000134817-APLNR/tissue (accessed January 17, 2019). O’Carroll, 2013, The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis, J. Endocrinol., 219 Kidoya, 2008, Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis, EMBO J., 27, 522, 10.1038/sj.emboj.7601982 Pauli, 2014, Toddler: an embryonic signal that promotes cell movement via apelin receptors, NIH Public Access., 343, 1 Chng, 2013, ELABELA: a hormone essential for heart development signals via the apelin receptor, Dev. Cell., 27, 672, 10.1016/j.devcel.2013.11.002 Ho, 2015, ELABELA is an endogenous growth factor that sustains hESC self-renewal via the PI3K/AKT pathway, Cell Stem Cell, 17, 435, 10.1016/j.stem.2015.08.010 Wang, 2015, Elabela-apelin receptor signaling pathway is functional in mammalian systems, Sci. Rep., 5, 1 Medhurst, 2003, Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin, J. Neurochem., 84, 1162, 10.1046/j.1471-4159.2003.01587.x Ho, 2017, ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice, Science, 357, 707, 10.1126/science.aam6607 Wang, 2017, Apelin as a novel drug for treating preeclampsia, Exp. Ther. Med., 14, 5917 Wallis, 2008, Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987–2004, Am. J. Hypertens., 21, 521, 10.1038/ajh.2008.20 Duley, 2009, The global impact of pre-eclampsia and eclampsia, Semin. Perinatol., 33, 130, 10.1053/j.semperi.2009.02.010 Brown, 2018, International society for the study of hypertension in pregnancy (ISSHP), hypertensive disorders of pregnancy, Hypertension, 72, 24, 10.1161/HYPERTENSIONAHA.117.10803 Roberts, 2003, Summary of the NHLBI working group on research on hypertension during pregnancy, Hypertension, 41, 437, 10.1161/01.HYP.0000054981.03589.E9 Raymond, 2011, A critical review of early-onset and late-onset preeclampsia, Obstet. Gynecol. Surv., 66, 497, 10.1097/OGX.0b013e3182331028 von Dadelszen, 2003, Subclassification of preeclampsia, Hypertens. Pregnancy, 22, 143, 10.1081/PRG-120021060 Crispi, 2006, Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction, Am. J. Obstet. Gynecol., 195, 201, 10.1016/j.ajog.2006.01.014 Valensise, 2008, Early and late preeclampsia, Hypertension, 52, 873, 10.1161/HYPERTENSIONAHA.108.117358 van der Merwe, 2010, Are early and late preeclampsia distinct subclasses of the disease—what does the placenta reveal?, Hypertens. Pregnancy, 29, 457, 10.3109/10641950903572282 Ihle, 1987, Early onset pre-eclampsia: recognition of underlying renal disease, Br. Med. J. (Clin. Res. Ed)., 294, 79, 10.1136/bmj.294.6564.79 Obed, 2006, Birth weight and ponderal index in pre-eclampsia: a comparative study, Ghana Med. J., 40, 8 Jeyabalan, 2013, Epidemiology of preeclampsia: impact of obesity, Nutr. Rev., 71, S18, 10.1111/nure.12055 Weissgerber, 2015, Preeclampsia and diabetes, Curr. Diab. Rep., 15, 9, 10.1007/s11892-015-0579-4 ACOG Committee on Obstetric Practice, ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists., Int. J. Gynaecol. Obstet. 77 (2002) 67–75. http://www.ncbi.nlm.nih.gov/pubmed/12094777 (accessed January 3, 2019). Pritchard, 2018, ELABELA/APELA levels are not decreased in the maternal circulation or placenta among women with preeclampsia, Am. J. Pathol., 188, 1749, 10.1016/j.ajpath.2018.04.008 Van Mieghem, 2016, Apelin in normal pregnancy and pregnancies complicated by placental insufficiency, Reprod. Sci., 23, 1037, 10.1177/1933719116630422 Kucur, 2014, Maternal serum apelin and YKL-40 levels in early and late-onset pre-eclampsia, Hypertens. Pregnancy, 33, 467, 10.3109/10641955.2014.944709 Inuzuka, 2013, Decreased expression of apelin in placentas from severe pre-eclampsia patients, Hypertens. Pregnancy, 32, 410, 10.3109/10641955.2013.813535 Bortoff, 2012, Decreased maternal plasma apelin concentrations in preeclampsia, Hypertens. Pregnancy, 31, 398, 10.3109/10641955.2012.690054 Yamaleyeva, 2015, Downregulation of apelin in the human placental chorionic villi from preeclamptic pregnancies, Am. J. Physiol. Metab., 309, E852 Panaitescu, 2018, ELABELA plasma concentrations are increased in women with late-onset preeclampsia, J. Matern. Neonatal Med., 1 Furuya, 2012, Expression of angiotensin II receptor-like 1 in the placentas of pregnancy-induced hypertension, Int. J. Gynecol. Pathol., 31, 227, 10.1097/PGP.0b013e31823b6e71 Colcimen, 2017, Investigation of role of vascular endothelial growth factor, Annexin A5 and Apelin by immunohistochemistry method in placenta of preeclampsia patients, Cell Mol. Biol., 63, 42, 10.14715/cmb/2017.63.11.8 Cobellis, 2007, Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas, Histol. Histopathol., 22, 1 Simsek, 2012, Serum levels of apelin, salusin-alpha and salusin-beta in normal pregnancy and preeclampsia, J. Matern. Neonatal Med., 31, 410 Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration, BMJ, 339, 10.1136/bmj.b2700 Catalano, 2006, Review article: the short- and long-term implications of maternal obesity on the mother and her offspring, BJOG Int. J. Obstet. Gynaecol., 113, 1126, 10.1111/j.1471-0528.2006.00989.x Ehrenberg, 2003, The influence of obesity and gestational diabetes mellitus on accretion and the distribution of adipose tissue in pregnancy, Am. J. Obstet. Gynecol., 189, 944, 10.1067/S0002-9378(03)00761-0 Bodnar, 2005, The risk of preeclampsia rises with increasing prepregnancy body mass index, Ann. Epidemiol., 15, 475, 10.1016/j.annepidem.2004.12.008 Krist, 2013, Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity, Obes. Facts, 6, 57, 10.1159/000348667 Zhou, 2019, ELABELA, as a potential diagnostic biomarker of pre-eclampsia, regulates abnormally shallow placentation via APJ, Am. J. Physiol. Metab., 5 Simenc, 2018, Is forty the new thirty? Population based study of advanced maternal age, J. Perinat. Med., 46, 247, 10.1515/jpm-2017-0060 Luke, 2007, Contemporary risks of maternal morbidity and adverse outcomes with increasing maternal age and plurality, Fertil. Steril., 88, 283, 10.1016/j.fertnstert.2006.11.008 Lamminpää, 2012, Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997–2008, BMC Pregnancy Childbirth, 12, 47, 10.1186/1471-2393-12-47 Kinzler, 2000, Medical and economic effects of twin gestations, J. Soc. Gynecol. Investig., 7, 321, 10.1177/107155760000700601 Bdolah, 2008, Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?, Am. J. Obstet. Gynecol., 10.1016/j.ajog.2007.10.783 Aviram, 2018, The role of placental malperfusion in the pathogenesis of preeclampsia in dichorionic twin and singleton pregnancies, Placenta, 70, 41, 10.1016/j.placenta.2018.09.002 Xiao, 2014, Is ethnicity a risk factor for developing preeclampsia? An analysis of the prevalence of preeclampsia in China, J. Hum. Hypertens., 28, 694, 10.1038/jhh.2013.148 Knuist, 1998, Risk factors for preeclampsia in nulliparous women in distinct ethnic groups: a prospective cohort study, Obstet. Gynecol., 92, 174 Rey, 1994, The prognosis of pregnancy in women with chronic hypertension, Am. J. Obstet. Gynecol., 171, 410, 10.1016/0002-9378(94)90276-3 Villie, 2018, Research Letter: Elabela concentration is not decreased in maternal plasma before the onset of preeclampsia, Am. J. Obstet. Gynecol., 220, 284, 10.1016/j.ajog.2018.12.020 Cox, 2006, Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo, Dev. Biol., 296, 177, 10.1016/j.ydbio.2006.04.452 Malamitsi-Puchner, 2007, Circulating apelin concentrations in mother/infant pairs at term, Acta Paediatr., 96, 1751, 10.1111/j.1651-2227.2007.00565.x Tomimatsu, 2017, Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction, Hypertens. Res., 40, 305, 10.1038/hr.2016.152 Lee, 2000, Characterization of apelin, the ligand for the APJ receptor, J. Neurochem., 74, 34, 10.1046/j.1471-4159.2000.0740034.x Chun, 2008, Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis, J. Clin. Invest., 118, 3343 Lee, 2005, Modification of the terminal residue of Apelin-13 antagonizes its hypotensive action, Endocrinology, 146, 231, 10.1210/en.2004-0359 Japp, 2010, Acute cardiovascular effects of Apelin in humans, Circulation, 121, 1818, 10.1161/CIRCULATIONAHA.109.911339 Barnes, 2013, Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure, Circ. Hear. Fail., 6, 482, 10.1161/CIRCHEARTFAILURE.111.000077